Literature DB >> 15742397

Expression and significance of Tie-1 and Tie-2 receptors, and angiopoietins-1, 2 and 4 in colorectal adenocarcinoma: Immunohistochemical analysis and correlation with clinicopathological factors.

Toshiyuki Nakayama1, Go Hatachi, Chun-Yang Wen, Ayumi Yoshizaki, Kazuyuki Yamazumi, Daisuke Niino, Ichiro Sekine.   

Abstract

AIM: There is strong evidence that tyrosine kinases are involved in the regulation of tumor progression, cellular growth and differentiation. Recently, many kinds of tyrosine kinase receptors have been reported, among them Tie-1 and Tie-2 receptors constitute a major class. Angiopoietin (Ang)-1 is known as a ligand of Tie-2 tyrosine kinase receptor. The objective of this study was to establish a comprehensive Tie-1 and Tie-2 and Ang-1, 2 and 4 expression profile in human colorectal adenocarcinomas.
METHODS: We examined 96 cases of surgically resected human colorectal adenocarcinoma by immunohistochemistry and investigated the statistical correlation between the expressions of Ties and Angs and clinicopathological factors.
RESULTS: Among the 96 cases of adenocarcinoma, 87 (90.6%), 92 (95.8%), 83 (86.5%), 89 (92.7%), and 76 cases (79.2%) showed positive staining in the cytoplasm of carcinoma cells for the Tie-1 and Tie-2 and Ang-1, 2 and 4 proteins, respectively. Histologically, the expressions of Ties and Angs were variable. The expressions of Ties and Angs were correlated with several clinicopathological factors, but did not correlate with the presence of lymph node metastasis. Ties and Angs were highly expressed in human colorectal adenocarcinoma cells.
CONCLUSION: These findings suggest that the Tie-Ang receptor-ligand complex is one of the factors involved in the cellular differentiation and progression of human colorectal adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15742397      PMCID: PMC4250786          DOI: 10.3748/wjg.v11.i7.964

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  34 in total

1.  Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues.

Authors:  A L Wong; Z A Haroon; S Werner; M W Dewhirst; C S Greenberg; K G Peters
Journal:  Circ Res       Date:  1997-10       Impact factor: 17.367

2.  Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation.

Authors:  T N Sato; Y Tozawa; U Deutsch; K Wolburg-Buchholz; Y Fujiwara; M Gendron-Maguire; T Gridley; H Wolburg; W Risau; Y Qin
Journal:  Nature       Date:  1995-07-06       Impact factor: 49.962

Review 3.  The angiopoietins: Yin and Yang in angiogenesis.

Authors:  S Davis; G D Yancopoulos
Journal:  Curr Top Microbiol Immunol       Date:  1999       Impact factor: 4.291

4.  Distinct rat genes with related profiles of expression define a TIE receptor tyrosine kinase family.

Authors:  P C Maisonpierre; M Goldfarb; G D Yancopoulos; G Gao
Journal:  Oncogene       Date:  1993-06       Impact factor: 9.867

5.  Association between invasiveness, inflammatory reaction, desmoplasia and survival in colorectal cancer.

Authors:  T B Halvorsen; E Seim
Journal:  J Clin Pathol       Date:  1989-02       Impact factor: 3.411

6.  Predominant expression of a receptor tyrosine kinase, TIE, in hematopoietic stem cells and B cells.

Authors:  M Hashiyama; A Iwama; K Ohshiro; K Kurozumi; K Yasunaga; Y Shimizu; Y Masuho; I Matsuda; N Yamaguchi; T Suda
Journal:  Blood       Date:  1996-01-01       Impact factor: 22.113

Review 7.  Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation.

Authors:  C J Marshall
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

8.  Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis.

Authors:  A Stratmann; W Risau; K H Plate
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

9.  Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2.

Authors:  P Lin; J A Buxton; A Acheson; C Radziejewski; P C Maisonpierre; G D Yancopoulos; K M Channon; L P Hale; M W Dewhirst; S E George; K G Peters
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

10.  Aberrant elevation of tyrosine-specific phosphorylation in human gastric cancer cells.

Authors:  E Takeshima; M Hamaguchi; T Watanabe; S Akiyama; M Kataoka; Y Ohnishi; H Y Xiao; Y Nagai; H Takagi
Journal:  Jpn J Cancer Res       Date:  1991-12
View more
  12 in total

Review 1.  Antiangiogenic therapy in human gastrointestinal malignancies.

Authors:  J Heidemann; D G Binion; W Domschke; T Kucharzik
Journal:  Gut       Date:  2006-10       Impact factor: 23.059

2.  Angiopoietin-4 inhibits angiogenesis and reduces interstitial fluid pressure.

Authors:  Minna W B Olsen; Carsten D Ley; Nanna Junker; Anker J Hansen; Eva L Lund; Paul E G Kristjansen
Journal:  Neoplasia       Date:  2006-05       Impact factor: 5.715

3.  Antisense angiopoietin-1 inhibits tumorigenesis and angiogenesis of gastric cancer.

Authors:  Jun Wang; Kai-Chun Wu; De-Xin Zhang; Dai-Ming Fan
Journal:  World J Gastroenterol       Date:  2006-04-21       Impact factor: 5.742

4.  Minimally invasive colorectal resection for cancer is associated with a short-lived decrease in soluble Tie-2 receptor levels, which may transiently inhibit VEGF-mediated angiogenesis (via altered blood levels of free Ang-1 and Ang-2).

Authors:  H M C Shantha Kumara; Michael J Grieco; Xiaohong Yan; Matthew F Kalady; Vincent DiMaggio; Donald G Kim; Neil Hyman; Daniel L Feingold; Richard L Whelan
Journal:  Surg Endosc       Date:  2010-03-31       Impact factor: 4.584

5.  Expression of angiopoietin-1, 2 and 4 and Tie-1 and 2 in gastrointestinal stromal tumor, leiomyoma and schwannoma.

Authors:  Toshiyuki Nakayama; Maki Inaba; Shinji Naito; Yumi Mihara; Shiro Miura; Mitsuru Taba; Ayumi Yoshizaki; Chun-Yang Wen; Ichiro Sekine
Journal:  World J Gastroenterol       Date:  2007-09-07       Impact factor: 5.742

6.  Circulating angiopoietin-2 and soluble Tie-2 in type 2 diabetes mellitus: a cross-sectional study.

Authors:  Sazan Rasul; Marie Helene Reiter; Aysegul Ilhan; Katharina Lampichler; Ludwig Wagner; Alexandra Kautzky-Willer
Journal:  Cardiovasc Diabetol       Date:  2011-06-23       Impact factor: 9.951

7.  Time-dependent changes of plasma concentrations of angiopoietins, vascular endothelial growth factor, and soluble forms of their receptors in nonsmall cell lung cancer patients following surgical resection.

Authors:  Ewa Kopczyńska; Maciej Dancewicz; Janusz Kowalewski; Roman Makarewicz; Hanna Kardymowicz; Agnieszka Kaczmarczyk; Tomasz Tyrakowski
Journal:  ISRN Oncol       Date:  2012-03-26

Review 8.  Intra and extravascular transmembrane signalling of angiopoietin-1-Tie2 receptor in health and disease.

Authors:  T Makinde; D K Agrawal
Journal:  J Cell Mol Med       Date:  2008-02-04       Impact factor: 5.310

9.  Suppression of angiogenesis and tumor growth in vitro and in vivo using an anti-angiopoietin-2 single-chain antibody.

Authors:  Zhong-Lin Zhang; Ji-Fa Zhang; Yu-Feng Yuan; Yue-Ming He; Quan-Yan Liu; Xiao-Wen Mao; Yong-Biao Ai; Zhi-Su Liu
Journal:  Exp Ther Med       Date:  2014-01-07       Impact factor: 2.447

10.  Tyrosine kinase receptor TIE-1 mediates platinum resistance by promoting nucleotide excision repair in ovarian cancer.

Authors:  Masumi Ishibashi; Masafumi Toyoshima; Xuewei Zhang; Junko Hasegawa-Minato; Shogo Shigeta; Toshinori Usui; Christopher J Kemp; Carla Grandori; Kazuyuki Kitatani; Nobuo Yaegashi
Journal:  Sci Rep       Date:  2018-09-04       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.